| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |